These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21547912)

  • 1. Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations.
    Poole RA; Kasper PT; Jiskoot W
    J Pharm Sci; 2011 Jul; 100(7):3018-22. PubMed ID: 21547912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate.
    Avanti C; Permentier HP; Dam Av; Poole R; Jiskoot W; Frijlink HW; Hinrichs WL
    Mol Pharm; 2012 Mar; 9(3):554-62. PubMed ID: 22257021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of water and polymer content on covalent amide-linked adduct formation in peptide-containing amorphous lyophiles.
    DeHart MP; Anderson BD
    J Pharm Sci; 2012 Sep; 101(9):3142-56. PubMed ID: 22437444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Wiśniewski A; Knioła D; Olejniczak M
    Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.
    Avanti C; Amorij JP; Setyaningsih D; Hawe A; Jiskoot W; Visser J; Kedrov A; Driessen AJ; Hinrichs WL; Frijlink HW
    AAPS J; 2011 Jun; 13(2):284-90. PubMed ID: 21448747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-buffering antibody formulations.
    Gokarn YR; Kras E; Nodgaard C; Dharmavaram V; Fesinmeyer RM; Hultgen H; Brych S; Remmele RL; Brems DN; Hershenson S
    J Pharm Sci; 2008 Aug; 97(8):3051-66. PubMed ID: 18023013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodegradation of oxytocin and thermal stability of photoproducts.
    Mozziconacci O; Schöneich C
    J Pharm Sci; 2012 Sep; 101(9):3331-46. PubMed ID: 22623074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.
    Hawe A; Poole R; Romeijn S; Kasper P; van der Heijden R; Jiskoot W
    Pharm Res; 2009 Jul; 26(7):1679-88. PubMed ID: 19343484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.
    Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH
    Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of oxytocin dimers is suppressed by the zinc-aspartate-oxytocin complex.
    Avanti C; Hinrichs WLJ; Casini A; Eissens AC; Van Dam A; Kedrov A; Driessen AJM; Frijlink HW; Permentier HP
    J Pharm Sci; 2013 Jun; 102(6):1734-1741. PubMed ID: 23589380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and mechanisms of deamidation and covalent amide-linked adduct formation in amorphous lyophiles of a model asparagine-containing Peptide.
    Dehart MP; Anderson BD
    Pharm Res; 2012 Oct; 29(10):2722-37. PubMed ID: 22006203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
    Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
    Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation.
    Gopalrathnam G; Sharma AN; Dodd SW; Huang L
    PDA J Pharm Sci Technol; 2018; 72(2):163-175. PubMed ID: 29343621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
    Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction between drug substances and pharmaceutical excipients: formation of citric acid esters and amides of carvedilol in the solid state.
    Larsen J; Cornett C; Jaroszewski JW; Hansen SH
    J Pharm Biomed Anal; 2009 Jan; 49(1):11-7. PubMed ID: 18996664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete NMR analysis of oxytocin in phosphate buffer.
    Ohno A; Kawasaki N; Fukuhara K; Okuda H; Yamaguchi T
    Magn Reson Chem; 2010 Feb; 48(2):168-72. PubMed ID: 20020419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Excipients Enhance Iron-Dependent Photo-Degradation in Pharmaceutical Buffers by near UV and Visible Light: Tyrosine Modification by Reactions of the Antioxidant Methionine in Citrate Buffer.
    Subelzu N; Schöneich C
    Pharm Res; 2021 May; 38(5):915-930. PubMed ID: 33881737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 'pH' on the Rate of Pyroglutamate Formation in Solution and Lyophilized Solids.
    Bersin LM; Patel SM; Topp EM
    Mol Pharm; 2021 Aug; 18(8):3116-3124. PubMed ID: 34232660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.